FDA inspection
SRI Krishna Pharmaceuticals Ltd: FDA inspection ending Apr 18, 2025
FDA inspection 1271116 · Voluntary Action Indicated (VAI) · Hyderabad
Key facts
| Inspection ID | 1271116 |
|---|---|
| Firm | SRI Krishna Pharmaceuticals Ltd |
| FEI number | 3003723117 |
| Address | C - 4 Industrial Area, Medchal - Malkajgiri; Uppal Khalsa |
| City | Hyderabad |
| Country | India |
| Fiscal year | 2025 |
| Inspection end date | Apr 18, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data